Literature DB >> 3884132

Enzymes, isozymes, and enzyme variants in the diagnosis of cancer. A short review.

M Stefanini.   

Abstract

Changes of enzyme activity in tissues, body fluids, and serum as well as changes of isozymes and enzyme variants in patients with malignancy suggest that these parameters may be used in the diagnosis of some types of cancer. A review of available information indicates that: changes of serum enzymes in patients with malignancies relate to the presence of a heavy tumor burden or of metastases, and cannot be utilized for the early diagnosis of malignancies; changes in isozyme patterns and newly developed enzyme variants may be of greater diagnostic value, although possibly not in the early diagnosis of cancer; study of enzymatic activity in body fluid may offer valuable help in specific situations; and occasionally, determination of enzymes may be of help in establishing susceptibility to malignancies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884132     DOI: 10.1002/1097-0142(19850501)55:9<1931::aid-cncr2820550917>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand.

Authors:  Raj K Koiri; Surendra K Trigun; Lallan Mishra; Kiran Pandey; Deobrat Dixit; Santosh K Dubey
Journal:  Invest New Drugs       Date:  2008-11-29       Impact factor: 3.850

2.  Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies.

Authors:  Venkatraman Magesh; Jayapal Prince Vijaya Singh; Karupaya Selvendiran; Ganapathy Ekambaram; Dhanapal Sakthisekaran
Journal:  Mol Cell Biochem       Date:  2006-05-10       Impact factor: 3.396

3.  Gossypol treatment of recurrent adult malignant gliomas.

Authors:  P Bushunow; M M Reidenberg; J Wasenko; J Winfield; B Lorenzo; S Lemke; B Himpler; R Corona; T Coyle
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

4.  Serum enzyme concentrations in untreated acute myeloid leukaemia.

Authors:  C S Scott; M Davey; A Hamilton; D R Norfolk
Journal:  Blut       Date:  1986-05

5.  Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.

Authors:  C Benz; C Hollander; M Keniry; T L James; M Mitchell
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

6.  Chemopreventive effect of bacoside A on N-nitrosodiethylamine-induced hepatocarcinogenesis in rats.

Authors:  Panneerselvam Janani; Kanakarajan Sivakumari; Arumugam Geetha; Baskaran Ravisankar; Chandrakesan Parthasarathy
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-15       Impact factor: 4.553

7.  Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML).

Authors:  A N Stark; J Thorogood; C Head; B E Roberts; C S Scott
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

8.  Comparative Study of Serum Lipid Profiles in Nepalese Cancerzzm321990Patients Attending a Tertiary Care Hospital

Authors:  Dipendra Raj Pandeya; Ajay Rajbhandari; Manoj Nepal; Ezeldine K Abdalhabib; Mahesh Bhatta; Sudha Sen Malla; Laxmi Upadhyay; Mohammed H Saiem Al Dahr
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.